| Title | Psoriasis disappearance after the first phase of an oncologic treatment: a serendipity case report. | | Author(s) | Cagiano R, Bera I, Vermesan D, Flace P, Sabatini R, Bottalico L, Auteri P, Santacroce L | | Institution | Departments of Pharmacology and Human Physiology, Medical Faculty, University of Bari, Italy. | | Source | Clin Ter 2008 Nov-Dec; 159(6):421-5. | | Abstract | Psoriasis is a multifaceted disorder with psychosocial and physical aspects that negatively impact the quality of life. Strategies of treatment must address both rapid control of the disease and maintenance of benefi ts. For short and long-term control of localized psoriasis, recent data support the combined use of topical corticosteroids and either calcipotriene or tazarotene which seem to be the most effective approach. For generalized disease, UVB treatment provides the safest means of achieving long-term control of the disease. Acitretin is a very helpful adjunct for improving the efficacy of phototherapy. For patients with severe, refractory disease, methotrexate may be most effective while cyclosporine may be most valuable for patients needing rapid, short-term improvement. Other molecules, with different pharmacological properties, are actually under consideration. Herein it is reported a case of a 55 year old male, who refers, 2 weeks after the fi rst cycle of oncologic therapy with gemcitabine and cisplatin for a lung neoplasm, about the complete remission of the psoriasis on both fi ngernails and scalp, suffered since almost ten years. Three months after the fortuitous detection of the psoriasis disappearance, there is no further evidence of psoriatic lesions. Clin Ter 2008; 159(6):421-425 Key words: cisplatin, gemcitabine, oncology, psori. | | Language | eng | | Pub Type(s) | Journal Article
| | PubMed ID | 19169602 |
|
